Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways Oncology
141-160 of 262 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.130329.1
Systematic Review metrics
Benefit of Asian pigmented rice bioactive compound and its implication in breast cancer: a systematic review
[version 1; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Wirdatun Nafisah, Alexander Patera Nugraha, Aditya Nugroho, Andi Isti Sakinah, Duano Sapta Nusantara, John Philia, Mohammad Iqbal Kurniawinata, Wirdatul Aini, Vika Tresnadiana Herlina, Tengku Natasha Eleena binti Tengku Ahmad Noor
Peer Reviewers Kok-Yong Chin; Ananto Ali Alhasyimi; Mohammed Aljunaid; Yuan Seng Wu
PUBLISHED 05 Apr 2023
https://doi.org/10.12688/f1000research.122987.2
Brief Report metrics
Revised
Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism
[version 2; peer review: 2 approved]
Colin J. Henderson, Aileen W. McLaren, Yury Kapelyukh, C. Roland Wolf
Peer Reviewers Russ Prough; Chris Goldring
  • Funders
  • Cancer Research UK
  • Medical Research Council
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 27 Mar 2023
https://doi.org/10.12688/f1000research.125858.1
Research Article metrics
Neutrophil/lymphocyte ratio and overall survival in patients with breast cancer: a cohort study in a Latin-American hospital
[version 1; peer review: 1 approved with reservations]
Nataly Briyit Huamán Córdova, Martha Sofia Cervera-Ocaña, Dante M. Quiñones-Laveriano, Jhony A. De La Cruz-Vargas
Peer Reviewers Helene Rundqvist and Marlene Rietz
PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.129860.2
Research Article metrics
Revised
Ocimum sanctum Linn. Ethanolic extract promotes an antiproliferative and apoptosis activity in MCF-7 and T47D breast cancer cell lines mediated by upregulation of ROS/RNS, Caspase 9, and Caspase 3: an in silico and in vitro study
[version 2; peer review: 1 approved, 1 not approved]
Hevi Wihadmadyatami, Srikanth Karnati, Suleyman Ergún, Ulayatul Kustiati, Dewi Ratih Tirtosari, Dwi Liliek Kusindarta, Yudy Tjahjono
Peer Reviewers Muhammad Lokman MD Isa; Stéphanie Grandemange
LATEST VERSION PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.131710.1
Review metrics PEER REVIEW DISCONTINUED
Data presentation of results from randomized cancer clinical trials. The case for trials in advanced cervical cancer. A critical appraisal.
[version 1; peer review: peer review discontinued]
Alfonso Duenas Gonzalez, Jaime Coronel, Paula Cabrera-Galeana, Myrna Candelaria, Claudia Cano-Blanco
Peer Reviewers Invited
  • Funder
  • The author declared that no grants were involved in supporting this work.
PUBLISHED 13 Mar 2023
https://doi.org/10.12688/f1000research.130888.1
Research Article metrics
Network biology of lapatinib resistance in different types of HER2-positive breast cancers informs the prioritization of the combination anticancer treatments as anti-resistance interventions
[version 1; peer review: 1 approved with reservations]
Bayan Alkhawaja, Anas Khaleel, Wael Abu Dayyih, Mohammed F. Hamad, Rima Hajjo, Mohammad Hailat
Peer Reviewers Wenjing Liu
PUBLISHED 09 Mar 2023
https://doi.org/10.12688/f1000research.130716.1
Clinical Practice Article metrics
Oncoplastic breast volume replacement with the use of lateral intercostal artery perforator flap
[version 1; peer review: 2 approved with reservations]
Sinta Chaira Maulanisa, I Gusti Ngurah Gunawan Wibisana
Peer Reviewers Dedy Hermansyah; Kanchana Wijesinghe
PUBLISHED 01 Mar 2023
https://doi.org/10.12688/f1000research.109136.2
Research Article metrics
Revised
Genomic profiles of Indonesian colorectal cancer patients
[version 2; peer review: 2 approved]
Murdani Abdullah, Sofy Meilany, Hidayat Trimarsanto, Safarina G. Malik, Ninik Sukartini, Firhat Idrus, Saskia A. Nursyirwan, Virly N. Muzellina, Rabbinu R. Pribadi, Amanda P. Utari, Hasan Maulahela, Ari F. Syam
Peer Reviewers Ahmad Rusdan Handoyo Utomo; Wei Zhang
  • Funder
  • Indonesian Ministry of Research, Technology, and Higher Education through the World Class Research (WCR) 2019 Program
LATEST VERSION PUBLISHED 21 Feb 2023
https://doi.org/10.12688/f1000research.129490.1
Research Article metrics
Toblerone: detecting exon deletion events in cancer using RNA-seq
[version 1; peer review: 2 approved]
Andrew Lonsdale, Andreas Halman, Lauren Brown, Hansen Kosasih, Paul Ekert, Alicia Oshlack
Peer Reviewers Katherine Pillman; Matt Field
  • Funder
  • National Health and Medical Research Council
PUBLISHED 03 Feb 2023
https://doi.org/10.12688/f1000research.127325.1
Research Article metrics
Multimorbidity in Sudanese women newly diagnosed with breast cancer: a retrospective cross-sectional study
[version 1; peer review: 1 approved with reservations]
Mohammed Alorini, Saeed Omar, Mutasim Abubaker, Ishag Adam
Peer Reviewers Phumudzo Ndwambi
PUBLISHED 23 Jan 2023
https://doi.org/10.12688/f1000research.129089.1
Opinion Article metrics
Genetic evolution and cellular interactions within the tumour microenvironment determine glioblastoma progression
[version 1; peer review: 1 approved]
Chloe Shard, Kimberley L. Alexander, Hui K. Gan, Guillermo A. Gomez
Peer Reviewers Dinorah Friedmann-Morvinski
  • Funders
  • Mark Hughes Foundation
  • James N Kirby Foundation
  • BF Foundation
  • Cure Brain Cancer Foundation
  • Charlie Teo Foundation
  • National Health and Medical Research Council
  • Neurosurgical Research Foundation
  • BrainStorm Brain Cancer Research
PUBLISHED 13 Jan 2023
https://doi.org/10.12688/f1000research.122872.1
Research Article metrics
Trends in pancreatic cancer incidence and mortality in the United States from 2000 to 2019; a SEER based study
[version 1; peer review: 2 approved with reservations]
Oluseyi Abidoye, Young Min Cho, Sheena Bhushan, Comfort Adewunmi, Hasan Choudhury
Peer Reviewers Haleh Amirian; Thomas Seufferlein
PUBLISHED 05 Jan 2023
https://doi.org/10.12688/f1000research.127528.1
Research Article metrics AWAITING PEER REVIEW
Impact of serum leptin and adiponectin levels on breast cancer in postmenopausal Iraqi women: an observational Study
[version 1; peer review: awaiting peer review]
Mohammed A. Abd, Shaymaa A. Abbas, Laith G. Shareef
Peer Reviewers Invited
PUBLISHED 23 Dec 2022
https://doi.org/10.12688/f1000research.110903.2
Software Tool Article metrics
Revised
SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery
[version 2; peer review: 2 approved]
Bahar Tercan, Guangrong Qin, Taek-Kyun Kim, Boris Aguilar, John Phan, William Longabaugh, David Pot, Christopher J. Kemp, Nyasha Chambwe, Ilya Shmulevich
Peer Reviewers Jane Usher; Nishanth Ulhas Nair
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 22 Dec 2022
https://doi.org/10.12688/f1000research.129084.1
Research Article metrics AWAITING PEER REVIEW
Three-dimensional wavelet decomposition-based radiomics analysis for tumor characterization in patients with oropharyngeal squamous cell carcinoma
[version 1; peer review: awaiting peer review]
Hassan Bagher-Ebadian, Farzan Siddiqui, Ahmed I. Ghanem, Benjamin Movsas, Indrin J. Chetty
Peer Reviewers Invited
  • Funder
  • Varian Medical Systems
PUBLISHED 21 Dec 2022
https://doi.org/10.12688/f1000research.108628.2
Review metrics
Revised
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
[version 2; peer review: 2 approved]
Freda Halim, Yohana Azhar, Suwarman ., Bethy Hernowo
Peer Reviewers Didik Setyo Heriyanto; Norbert Nass
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.109551.2
Brief Report metrics
Revised
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease
[version 2; peer review: 2 approved]
Maki Hirao, Kohei Yamazaki, Kentaro Watanabe, Kiyoshi Mukai, Shigemichi Hirose, Makoto Osada, Yuiko Tsukada, Hisako Kunieda, Ryunosuke Denda, Takahide Kikuchi, Hiroki Sugimori, Shinichiro Okamoto, Yutaka Hattori
Peer Reviewers Antonio Bedalov; Makoto Sasaki
  • Funders
  • Japanese Society of Hematology
  • Ministry of Education, Culture, Sports, Science and Technology
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.127427.1
Case Report metrics
Case Report: Spontaneous remission of early T-cell precursor acute lymphoblastic leukemia
[version 1; peer review: 1 approved with reservations]
Amira Cherif, Veronique Saada, Amina Bouatay
Peer Reviewers Rosana Pelayo
PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.122339.1
Case Report metrics
Case Report: Invasive micropapillary ductal breast carcinoma
[version 1; peer review: 1 approved with reservations]
Kakia Anne Faith Namugenyi, Kelechi Elizabeth Oladimeji, Alungile Mthimba, Chris Mzileni, Olanrewaju Oladimeji
Peer Reviewers Georgios-Ioannis Verras and Francesk Mulita
  • Funders
  • National Research Foundation for Evaluated Researchers
  • Fogarty International Center and the National Institutes of Mental Health of the National Institutes of Health
PUBLISHED 18 Nov 2022
https://doi.org/10.12688/f1000research.126754.1
Research Article metrics
Tumour cell suppression by spiroleucettadine through dual regulation of cell cycle and apoptosis
[version 1; peer review: 1 approved]
Ben Watts, Maddie Berry, Abigail Bland, Michael Badart, Bill Hawkins, John Ashton
Peer Reviewers Brad Sutherland
  • Funder
  • University of Otago
PUBLISHED 16 Nov 2022
141-160 of 262 ARTICLES
Previous Next
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.